Additionally, clinical trials involving HDAC modulators have demonstrated that HDAC inhibition is an effective treatment for retinal diseases, including retinal degenerative diseases (Birch et al., 2018; Chen et al., 2019). The gene discussed is HDAC9; the disease is Abnormal retinal morphology.